Seattle Cancer Care Alliance, now Fred Hutchinson Cancer Center, the only National Cancer Institute (NCI)-designated cancer center in Washington, will have more than 20 clinicians presenting at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting from June 3-7, 2022 in Chicago.
The COVID-19 and Cancer Consortium (CCC19) published new findings in the Annals of Oncology, showing heightened mortality and racial disparities for patients with cancer diagnosed with SARS-CoV-2 infection.
Seattle Cancer Care Alliance (SCCA), the only NCCN-designated cancer center in Washington State, has been selected as an authorized treatment center for the new chimeric antigen receptor (CAR) T-cell therapy lisocabtagene maraleucel, also known as liso-cel and by the brand name BreyanziTM. Liso-cel was approved by the U.S. Food and Drug Administration (FDA) on February 5, 2021.
Seattle Cancer Care Alliance (SCCA), the only National Comprehensive Cancer Network (NCCN)-designated cancer center in Washington state, has been selected as an authorized treatment center to offer brexucabtagene autoleucel, also known by the brand name TecartusTM. It is the first and only chimeric antigen receptor (CAR) T-cell therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL).
Seattle Cancer Care Alliance (SCCA), committed to delivering patient-centered, high-quality cancer care as the only NCCN-designated cancer center in Washington State, announced that members of its clinical nursing staff will participate in 10 poster presentations during the 2020 Oncology Nursing Society (ONS) Bridge Virtual Conference. The meeting is being held September 8, 10, 15 and 17, 2020.
Seattle Met, a monthly magazine that reports on Seattle politics, arts and community, released its annual Top Doctors list today, featuring 68 Seattle Cancer Care Alliance (SCCA) doctors, physician assistants and nurse practitioners.
UWMC/ Seattle Cancer Care Alliance (SCCA), part of Washington state’s only National Cancer Institute (NCI)-designated comprehensive cancer center, has been recognized as the 9th Best Cancer Hospital for 2020-21 by U.S. News & World Report, and the only ranked number one cancer hospital in the Pacific Northwest for more than ten years. The annual Best Hospitals rankings and ratings, now in their 31st year, are designed to assist patients and their doctors in making informed decisions about where to receive care for challenging health conditions or for common elective procedures.
Seattle Cancer Care Alliance (SCCA) announced that Paula Rosput Reynolds will become chair of its Board of Directors. Reynolds takes the helm of the SCCA board from Karen Glover, who served as chair since 2018.
Seattle Cancer Care Alliance (SCCA) announced the beginning of construction on its South Lake Union (SLU) campus to add a new six-story, 150,000 square-foot outpatient cancer treatment clinic.
Genitourinary cancer specialists from Seattle Cancer Care Alliance, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, and Weill Cornell Medicine have published an article , “Reconsidering the Trade-offs of Prostate Cancer Screening,” in the New England Journal of Medicine on the long-term benefits of prostate-specific antigen (PSA) screening for prostate cancer in men. In the article, investigators concluded that the advantages of widespread screening – including reduced mortality and the potential to avoid metastases – are likely greater than estimates cited in current guidelines.
During a plenary session of the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program, findings will be presented from the global phase III JAVELIN Bladder 100 randomized study conducted by investigators from Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center and University of Washington Medicine along with several other research centers. The results demonstrated significantly prolonged overall survival of patients with locally advanced (unresectable) or metastatic urothelial cancer when treated with first-line immunotherapy avelumab plus best supportive care (BSC) compared to BSC alone (following disease control on induction chemotherapy).
Fred Hutchinson Cancer Research Center and its clinical-care partner, Seattle Cancer Care Alliance, announced today the organizations are receiving a $500,000 grant from Bank of America for COVID-19 relief.
Seattle Cancer Care Alliance (SCCA) announced today that Aaron Crane is the Alliance’s new Executive Vice President. Crane will lead the organization’s strategic development, including SCCA’s long-range financial plan and the upcoming clinic expansion at SCCA’s South Lake Union campus.
News and interview opportunities at Seattle Cancer Care Alliance
Interested in learning more about any of the updates described below? Contact us at [email protected]
On September 19 and 20, 2019, SCCA will celebrate its second Immunotherapy Symposium in Seattle, WA.
More than 20 physicians and researchers from Seattle Cancer Care Alliance (SCCA) will present at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL May 31 – June 4, 2019.
Inspired by its 2016–2019 Community Benefit Strategic Implementation Plan, Seattle Cancer Care Alliance (SCCA) today announced three community benefit grant recipients: Stilly Valley Health Connections, Cierra Sisters and the Korean Women’s Association.
Seattle Cancer Care Alliance is opening two new patient care centers in Issaquah, WA and in Poulsbo, WA.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right